Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
about
Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agentsImmunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.Targeting Insulin-Like Growth Factor Binding Protein-3 Signaling in Triple-Negative Breast CancerPotentiation of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activityInsulin-like growth factor-binding protein-3 and breast cancer survivalPrimate mammary gland insulin-like growth factor system: cellular localization and regulation by sex steroids.Insulin-like growth factors in human breast cancer.Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?IGFBP3 mRNA expression in benign and malignant breast tumorsIGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth.Through the looking glass at early-life exposures and breast cancer risk.Breast cancer: further metabolic-endocrine risk markers?Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA PathwaysExpression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancerIGF binding proteins (IGFBPs) and regulation of breast cancer biology.Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling.Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases.Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation.Fas-Fas ligand signaling pathway mediates an interleukin-12-induced rejection of a murine prostate tumor system.Growth inhibition and cytotoxicity induced by Bowman-Birk inhibitor concentrate in cisplatin-resistant human ovarian cancer cells.IGF system components as prognostic markers in breast cancer.Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with cIncreased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.Immunohistochemical analysis of prostate specific antigen in breast cancer.Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells.Triple-negative breast cancer and its association with obesity.Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy.
P2860
Q21195187-9967B3E4-2287-4C65-A9E0-3749CC9A6CE5Q24304487-623361B1-8848-467A-8DAC-C2654CE6FE06Q24796824-DBAB4A12-1415-445E-8FAE-B0CB93175F81Q26801886-50A8247E-6611-4A52-AE48-013707781377Q28253045-2705D776-A797-49B7-9749-C5CDB9836F71Q28290692-B71BACDB-567C-4FB8-AC18-3AF6C86E277FQ32056605-F50A6714-C8C6-4448-A68D-513CF95B9A7FQ33538445-A6D89C5A-160A-4215-91FA-E2875EEF747FQ35001398-20F58F0B-7397-4BAF-AAD3-AC6BF4830798Q35157568-F0923BC2-C63E-41D6-8BD6-41EE3669AA54Q35749398-9BDBD99F-748E-4C88-A8C2-8B83734052A6Q35973404-C5A0DACC-4038-4082-A279-D3A44F7CF0C1Q36321391-59989B35-2B6A-4DA5-A4FF-B59EEE225642Q36431629-E3DB9DE5-2386-4960-92EA-1C7E17914BE5Q36593417-CE6B1906-A76E-43C8-B531-9A92ECD8CA26Q36618953-1E79BB9E-C5E6-439D-9727-9126AF5414DAQ37334106-E15BD029-DFE2-402C-9CCC-D877803F9A24Q38323773-FF9F4327-F7F5-4694-83DB-EA8DBFC29780Q39827167-87CCF33C-B236-48F9-8114-1A530A16812FQ40689818-EB11067F-FC5C-4368-8B45-45303CCF7D03Q40700714-86BF3A02-50F4-401C-AD97-ACAD2CE4658EQ40706697-1F8FD9FF-9E0C-4AD6-920E-77A592A9BC11Q41021328-9192B844-1932-44AA-A01C-615661A74B96Q41727250-DBDC2CFE-50F7-44AC-8662-CA95B0E505FEQ42267666-1C04D384-EE78-4173-9544-C8964C416BF9Q42444415-C5D6D443-FC84-4E77-9096-4CA54AA56176Q43785975-A68C8165-893B-419A-9B42-4D882535E889Q43869797-2A4E8A0D-DB05-44E5-8A25-F28AA5BB5309Q47099775-C2177666-9084-4ECD-A4C4-6816DFF3D92BQ54117329-C8E33F76-643D-4CFA-878C-3210DD69B192
P2860
Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Associations between insulin-l ...... c indicators in breast cancer.
@ast
Associations between insulin-l ...... c indicators in breast cancer.
@en
type
label
Associations between insulin-l ...... c indicators in breast cancer.
@ast
Associations between insulin-l ...... c indicators in breast cancer.
@en
prefLabel
Associations between insulin-l ...... c indicators in breast cancer.
@ast
Associations between insulin-l ...... c indicators in breast cancer.
@en
P2093
P2860
P356
P1476
Associations between insulin-l ...... c indicators in breast cancer.
@en
P2093
A Papanastasiou-Diamandi
E P Diamandis
M A Levesque
M J Khosravi
P2860
P2888
P304
P356
10.1038/BJC.1996.523
P407
P577
1996-10-01T00:00:00Z